Back to Search Start Over

Taking Charge after Stroke: A randomized controlled trial of a person-centered, self-directed rehabilitation intervention.

Authors :
Fu, Vivian
Weatherall, Mark
McPherson, Kathryn
Taylor, William
McRae, Anna
Thomson, Tom
Gommans, John
Green, Geoff
Harwood, Matire
Ranta, Annemarei
Hanger, Carl
Riley, Judith
McNaughton, Harry
Source :
International Journal of Stroke; Dec2020, Vol. 15 Issue 9, p954-964, 11p
Publication Year :
2020

Abstract

Background and purpose: "Take Charge" is a novel, community-based self-directed rehabilitation intervention which helps a person with stroke take charge of their own recovery. In a previous randomized controlled trial, a single Take Charge session improved independence and health-related quality of life 12 months following stroke in Māori and Pacific New Zealanders. We tested the same intervention in three doses (zero, one, or two sessions) in a larger study and in a broader non-Māori and non-Pacific population with stroke. We aimed to confirm whether the Take Charge intervention improved quality of life at 12 months after stroke in a different population and whether two sessions were more effective than one. Methods: We randomized 400 people within 16 weeks of acute stroke who had been discharged to institution-free community living at seven centers in New Zealand to a single Take Charge session (TC1, n = 132), two Take Charge sessions six weeks apart (TC2, n = 138), or a control intervention (n = 130). Take Charge is a "talking therapy" that encourages a sense of purpose, autonomy, mastery, and connectedness with others. The primary outcome was the Physical Component Summary score of the Short Form 36 at 12 months following stroke comparing any Take Charge intervention to control. Results: Of the 400 people randomized (mean age 72.2 years, 58.5% male), 10 died and two withdrew from the study. The remaining 388 (97%) people were followed up at 12 months after stroke. Twelve months following stroke, participants in either of the TC groups (i.e. TC1 + TC2) scored 2.9 (95% confidence intervals (CI) 0.95 to 4.9, p = 0.004) points higher (better) than control on the Short Form 36 Physical Component Summary. This difference remained significant when adjusted for pre-specified baseline variables. There was a dose effect with Short Form 36 Physical Component Summary scores increasing by 1.9 points (95% CI 0.8 to 3.1, p < 0.001) for each extra Take Charge session received. Exposure to the Take Charge intervention was associated with reduced odds of being dependent (modified Rankin Scale 3 to 5) at 12 months (TC1 + TC2 12% versus control 19.5%, odds ratio 0.55, 95% CI 0.31 to 0.99, p = 0.045). Conclusions: Confirming the previous randomized controlled trial outcome, Take Charge—a low-cost, person-centered, self-directed rehabilitation intervention after stroke—improved health-related quality of life and independence. Clinical trial registration-URL: http://www.anzctr.org.au. Unique identifier: ACTRN12615001163594 [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17474930
Volume :
15
Issue :
9
Database :
Complementary Index
Journal :
International Journal of Stroke
Publication Type :
Academic Journal
Accession number :
147624896
Full Text :
https://doi.org/10.1177/1747493020915144